GLP 1
Orforglipron Latest Research: New Indications, Trials & What’s Coming
Orforglipron is Eli Lilly’s lead small-molecule GLP-1 receptor agonist.
Orforglipron Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Introduction Orforglipron eligibility looks similar to other GLP-1 receptor agonists in the obesity and diabetes space, with one twist: oral dosing changes which patients…
Orforglipron Drug Interactions: What You Can and Can’t Take with It
Orforglipron’s drug interaction profile is shaped by two mechanisms.
Orforglipron Dosing Guide: Schedule, Titration & What to Expect Each Week
Orforglipron is dosed once daily by mouth. In the phase 3 ACHIEVE-1 trial (Frias et al.
Orforglipron Cost Breakdown: Brand, Compounded, Insurance & Savings Options
Orforglipron isn’t FDA-approved yet, so there is no published list price.
Oral Semaglutide Cost Breakdown: Brand, Compounded, Insurance and Savings Options
Rybelsus (oral semaglutide) is one of the more expensive type 2 diabetes drugs on the US market in 2026.
Online Pharmacy vs Local Pharmacy for GLP-1
You’ve got a prescription for semaglutide or tirzepatide. Now the question nobody trained you for: where do you actually fill it?
Next-Generation GLP-1 Drugs: What’s in the Pipeline for 2026-2030
The current GLP-1 medications, semaglutide and tirzepatide, produce 15 to 21% weight loss in pivotal trials. That number is going to climb.
Needle Gauge Guide: Which Size for Which Medication
Needle gauge is one of those numbers patients see on the syringe label and assume someone smart picked for them.
